)
Tuhin Bhowmick
CEO & Co-founder,
Pandorum Technologies
Tuhin Bhowmick, PhD, is the Co-Founder and CEO of Pandorum Technologies, a biotech company developing regenerative therapies using clinical-grade stem cells. He holds a PhD in Macromolecular Crystallography from the Indian Institute of Science and completed postdoctoral research at the European Molecular Biology Laboratory as an EIPOD fellow.
Dr. Bhowmick has led the development of Kuragenx, a liquid cornea therapy recognized by ARVO and designated as an orphan drug by the FDA. His work bridges science and medicine to advance innovative solutions in tissue engineering and regenerative medicine.